Peter Heisig
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria 35
- Endocrinology top 1%
- Communication top 1%
- Knowledge Management and Sharing 10
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 6
-
- Antibiotics Pharmacokinetics and Efficacy 22
-
- Cancer therapeutics and mechanisms 16
-
- Antimicrobial Resistance in Staphylococcus 7
-
- Innovation and Knowledge Management 6
-
- Bacterial Genetics and Biotechnology 6
- Co-authors
- B. WiedemannJens VorbeckKai MertinsAnke HeisigFlorinda MatosArne C. RodloffGunnar KahlmeterGian María Rossolini
- Journals
- Antimicrobial Agents and Chemotherapy (16 papers)Journal of Antimicrobial Chemotherapy (7 papers)Journal of Knowledge Management (6 papers)
- Partner nations
- GermanyUnited KingdomAustralia
In The Last Decade
Peter Heisig
85 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 181
- Molecular Medicine 1.5k
- Endocrinology 473
- Communication 443
- Applied Microbiology and Biotechnology 117
- Clinical Biochemistry 325
Countries citing papers authored by Peter Heisig
This map shows the geographic impact of Peter Heisig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Heisig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Heisig more than expected).
Fields of papers citing papers by Peter Heisig
This network shows the impact of papers produced by Peter Heisig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Heisig. The network helps show where Peter Heisig may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Heisig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 6 | |
| 2 | 2020 | 8 | |
| 3 | PROtEUS++: A Self-managed IoT Workflow Engine with Dynamic Service Discovery. | 2017 | 2 |
| 4 | 2016 | 16 | |
| 5 | 2015 | 8 | |
| 6 | Knowledge Management – Advancements and Future Research Needs – Results from the Global Knowledge Research Network study | 2015 | 13 |
| 7 | ENGINEERS ARE USING SOCIAL MEDIA FOR WORK PURPOSES | 2014 | 6 |
| 8 | 2014 | 36 | |
| 9 | 2011 | 17 | |
| 10 | Using connectivity models to support design reviews | 2010 | 3 |
| 11 | 2010 | 68 | |
| 12 | 2008 | 16 | |
| 13 | 2006 | 17 | |
| 14 | 2003 | 6 | |
| 15 | 2001 | 31 | |
| 16 | 1997 | 19 | |
| 17 | 1995 | 0 | |
| 18 | 1994 | 67 | |
| 19 | 1994 | 30 | |
| 20 | 1993 | 86 |
About Peter Heisig
Peter Heisig is a scholar working on Molecular Medicine, Communication, Pharmacology, Endocrinology and Clinical Biochemistry, having authored 88 papers that have together received 3.9k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (35 papers), Antibiotics Pharmacokinetics and Efficacy (22 papers), Cancer therapeutics and mechanisms (16 papers), Knowledge Management and Sharing (10 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Innovation and Knowledge Management (6 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Bacterial Genetics and Biotechnology (6 papers). The work is most often cited by research in Molecular Medicine (1.5k citations), Endocrinology (473 citations), Communication (443 citations), Applied Microbiology and Biotechnology (117 citations) and Clinical Biochemistry (325 citations). Peter Heisig has collaborated with scholars based in Germany, United Kingdom and Australia. Frequent co-authors include B. Wiedemann, Jens Vorbeck, Kai Mertins, Anke Heisig, Florinda Matos, Arne C. Rodloff, Gunnar Kahlmeter, Gian María Rossolini, Johan W. Mouton and Christian G. Giske. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Journal of Knowledge Management, Microbial Drug Resistance and Bioorganic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.